Home | Sitemap | Search | ContactA- A A+
   
 
    Public Member Support us  
 

Trial IV 

Adjuvant therapy for postmenopausal; 65 years of younger, node positive breast cancer patients: observation vs. prednisone + tamoxifen vx. prednisone + tamoxifen

DESIGN

Design Trial IV

Results & Publications


Presentations


Publications

Study Chair
Prof. Aron Goldhirsch - Milano, Italy

Statistician
Karen Price

Lead Trial Coordinator
Holly Shaw

Director of Data Management
Lynette Blacher

IBCSG Data Management Center/FSTRF
4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 834 0900
Fax: +1 716 833 3990
Email: ibcsgI-IV@fstrf.org

Date of Activation
July 1, 1978

Date of Closure
September 1, 1981

Final Accrual
1713 patients (1601 evaluable patients)

Results Publications Results & Publications


News

23.03.2018:
The next IBCSG Annual Meeting will take place in Barcelona, Spain on March 23 and 24, 2018

03.09.2017:
RACE FOR LIFE - mit Power gegen Krebs am 3. September 2017 in Bern  

15.06.2017:
PINK GOLF TOUR 2017 für die Brustkrebs-Prävention  

All News

 
  Print